2nd Annual Optimizing Preclinical Outsourcing
Outsourcing Pharma/Biotech Non-Clinical Studies to Support the Efficient Evaluation of New Compounds
| Type | Conference |
|---|---|
| Language | English |
| Date |
June 26, 2006
to June 28, 2006 |
| Venue |
Royal Sonesta Hotel Boston Cambridge, MA US |
| Chemistry Specialties |
|
| Chemistry Techniques |
|
| Contact |
Charlie Haynes IIR USA 708 Third Avenue, 4th Floor New York, NY 10017 US 888-670-8200 941-365-2507 register@iirusa.com |
| Add event to calendar |
|
"Time, cost, quality and flexibility—key components to a preclinical outsourcing relationship—are not easy to balance. The volatility of shifting goals, study start dates and changes to study designs, availability of study subjects and testing facilities at the lab and budgetary decisions that may not be aligned with an outsourcing strategy all contribute to the success or failure of a project. Preclinical outsourcing is on the rise and with it, there is an increased demand for capacity at outsourced facilities. Our 2nd annual conference covers the critical elements to streamline preclinical projects and help sponsors and providers do a better job of working together to kill unsuccessful compounds and promote promising candidates faster. The Institute for International Research is delighted to present the 2nd annual conference on Optimizing Preclinical Outsourcing. IIR has over 15 years of experience organizing pharmaceutical outsourcing conferences that deliver best practices for tactical and strategic interactions between pharmaceutical and biotech companies and their R & D service providers."
